MARKET

CERS

CERS

Cerus
NASDAQ
2.350
+0.030
+1.29%
After Hours: 2.350 0 0.00% 19:57 08/07 EDT
OPEN
2.300
PREV CLOSE
2.320
HIGH
2.430
LOW
2.300
VOLUME
3.48M
TURNOVER
--
52 WEEK HIGH
3.470
52 WEEK LOW
1.150
MARKET CAP
473.58M
P/E (TTM)
-67.9191
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CERS last week (0727-0731)?
Weekly Report · 5d ago
Cerus Down Over 26%, On Pace for Largest Percent Decrease Since January 2023 -- Data Talk
Dow Jones · 07/31 17:01
Midday Fly By: Apple sinks after guidance, Amazon’s AWS powers beat
TipRanks · 07/31 16:17
Friday's ETF Movers: GXUS, ARKK
NASDAQ · 07/31 16:03
Apple, Stryker, Coinbase And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
Benzinga · 07/31 12:03
Cerus (CERS): Strong 2Q26 Results, Upgraded Full‑Year Guidance and INTERCEPT Momentum Underpin Buy Rating
TipRanks · 07/31 06:05
Cerus Q2 Earnings Call Highlights
NASDAQ · 07/30 22:04
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 07/30 21:05
More
About CERS
Cerus Corporation is a biomedical products company. The Company is focused on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System, which is based on its proprietary technology for controlling biological replication, is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. Its INTERCEPT Blood System is intended for use with blood components and certain of their derivatives: platelets, plasma, red blood cells and to produce INTERCEPT Fibrinogen Complex (IFC), and pathogen reduced plasma, cryoprecipitate reduced. The INTERCEPT Blood System for Cryoprecipitation uses its plasma system to produce IFC for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. In addition, the INTERCEPT Blood System for Cryoprecipitation is used to produce pathogen reduced plasma, cryoprecipitate reduced.

Webull offers Cerus Corp stock information, including NASDAQ: CERS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CERS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CERS stock methods without spending real money on the virtual paper trading platform.